Money Concepts Capital Corp Reduces Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Money Concepts Capital Corp lowered its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 19.8% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,433 shares of the medical equipment provider's stock after selling 600 shares during the quarter. Money Concepts Capital Corp's holdings in Intuitive Surgical were worth $1,205,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the company. Brighton Jones LLC increased its holdings in Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock worth $1,916,000 after buying an additional 731 shares in the last quarter. Bank Pictet & Cie Europe AG grew its stake in shares of Intuitive Surgical by 0.5% during the 4th quarter. Bank Pictet & Cie Europe AG now owns 190,969 shares of the medical equipment provider's stock valued at $99,678,000 after purchasing an additional 883 shares during the period. Whipplewood Advisors LLC bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at about $269,000. Kovack Advisors Inc. grew its stake in shares of Intuitive Surgical by 21.5% during the 4th quarter. Kovack Advisors Inc. now owns 1,686 shares of the medical equipment provider's stock valued at $880,000 after acquiring an additional 298 shares during the period. Finally, Versor Investments LP bought a new position in shares of Intuitive Surgical during the 4th quarter valued at approximately $248,000. Hedge funds and other institutional investors own 83.64% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have weighed in on ISRG shares. Evercore ISI dropped their price target on Intuitive Surgical from $510.00 to $470.00 and set an "in-line" rating for the company in a research note on Wednesday, April 23rd. Robert W. Baird decreased their price target on Intuitive Surgical from $600.00 to $575.00 and set an "outperform" rating on the stock in a report on Wednesday, April 23rd. Barclays decreased their price target on Intuitive Surgical from $684.00 to $635.00 and set an "overweight" rating on the stock in a report on Thursday, April 24th. Truist Financial lowered their target price on shares of Intuitive Surgical from $605.00 to $590.00 and set a "buy" rating for the company in a research note on Wednesday, April 23rd. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Intuitive Surgical from a "hold" rating to a "sell" rating and lowered their target price for the company from $515.00 to $440.00 in a research note on Monday, June 9th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical presently has a consensus rating of "Moderate Buy" and a consensus target price of $588.95.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Jami K. Nachtsheim sold 2,400 shares of the business's stock in a transaction that occurred on Thursday, May 1st. The stock was sold at an average price of $520.00, for a total value of $1,248,000.00. Following the completion of the transaction, the director now directly owns 6,371 shares of the company's stock, valued at approximately $3,312,920. The trade was a 27.36% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Gary Loeb sold 1,700 shares of the business's stock in a transaction that occurred on Friday, April 25th. The shares were sold at an average price of $513.18, for a total value of $872,406.00. Following the completion of the transaction, the executive vice president now directly owns 2,245 shares of the company's stock, valued at $1,152,089.10. The trade was a 43.09% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 4,998 shares of company stock valued at $2,611,577. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Performance

ISRG traded down $0.48 on Friday, hitting $533.71. The company had a trading volume of 2,014,026 shares, compared to its average volume of 1,669,756. The stock has a fifty day moving average price of $532.08 and a 200-day moving average price of $536.75. Intuitive Surgical, Inc. has a 12-month low of $413.82 and a 12-month high of $616.00. The stock has a market capitalization of $191.29 billion, a price-to-earnings ratio of 78.26, a P/E/G ratio of 5.66 and a beta of 1.67.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.71 by $0.10. The business had revenue of $2.25 billion during the quarter, compared to the consensus estimate of $2.19 billion. Intuitive Surgical had a return on equity of 14.43% and a net margin of 28.41%. During the same quarter last year, the company earned $1.50 earnings per share. Analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.